Literature DB >> 23678447

Novel aldehyde-terminated dendrimers; synthesis and cytotoxicity assay.

Aliasghar Hamidi1, Simin Sharifi, Soodabeh Davaran, Saeed Ghasemi, Yadollah Omidi, Mohammad-Reza Rashidi.   

Abstract

INTRODUCTION: Polyamidoamine (PAMAM) dendrimers are a unique family of dendritic polymers with numerous pharmaceutical and biomedical applications. One major problem with these polymers is their cytotoxicity. The purpose of this study was to synthesize novel dendrimers with aldehyde terminal groups and compare their cytotoxicity with that of dendri¬mers containing amine-terminated groups.
METHODS: G1(first generation) and G2 (second generation) dendrimers with amine-terminated groups were synthesized by divergent method and then the amine-terminated groups were converted to the aldehyde groups using surface modification of the functional group inversion (FGI) method. The cytotoxicity of the novel G1 and G2 polyamidoaldehyde (PAMAL) dendrimers together with that of G1 and G2 PAMAM-NH2 dendrimers was investigated by MTT assay using MCF-7 cell line.
RESULTS: The results showed that cytotoxicity of dendrimers with aldehyde-terminated groups is much lower than that of G1 and G2 PAMAM-NH2 dendri¬mers.
CONCLUSION: Dendrimers with aldehyde-terminated groups could be used as novel and convenient carriers for drug delivery with low cytotoxic effect compared with the amine-terminated dendrimers. The results revealed that the same generations of the dendri¬mers with aldehyde-terminated groups are far less toxic than the corresponding amine-terminated dendrimers.

Entities:  

Keywords:  Cytotoxicity; Dendrimers; FGI Method; MTT Assay; PAMAM

Year:  2012        PMID: 23678447      PMCID: PMC3648925          DOI: 10.5681/bi.2012.014

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  9 in total

1.  Polymeric systems for controlled drug release.

Authors:  K E Uhrich; S M Cannizzaro; R S Langer; K M Shakesheff
Journal:  Chem Rev       Date:  1999-11-10       Impact factor: 60.622

Review 2.  Dendrimer biocompatibility and toxicity.

Authors:  Ruth Duncan; Lorella Izzo
Journal:  Adv Drug Deliv Rev       Date:  2005-11-16       Impact factor: 15.470

Review 3.  Dendrimer toxicity: Let's meet the challenge.

Authors:  Keerti Jain; Prashant Kesharwani; Umesh Gupta; N K Jain
Journal:  Int J Pharm       Date:  2010-04-28       Impact factor: 5.875

Review 4.  Transepithelial and endothelial transport of poly (amidoamine) dendrimers.

Authors:  Kelly M Kitchens; Mohamed E H El-Sayed; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2005-11-11       Impact factor: 15.470

5.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo.

Authors:  N Malik; R Wiwattanapatapee; R Klopsch; K Lorenz; H Frey; J W Weener; E W Meijer; W Paulus; R Duncan
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

6.  Cytotoxic impacts of linear and branched polyethylenimine nanostructures in a431 cells.

Authors:  Vala Kafil; Yadollah Omidi
Journal:  Bioimpacts       Date:  2011-06-09

7.  The influence of surface modification on the cytotoxicity of PAMAM dendrimers.

Authors:  R Jevprasesphant; J Penny; R Jalal; D Attwood; N B McKeown; A D'Emanuele
Journal:  Int J Pharm       Date:  2003-02-18       Impact factor: 5.875

8.  Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture.

Authors:  A H Cory; T C Owen; J A Barltrop; J G Cory
Journal:  Cancer Commun       Date:  1991-07

9.  The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability.

Authors:  Antony D'Emanuele; Rachaneekorn Jevprasesphant; Jeffrey Penny; David Attwood
Journal:  J Control Release       Date:  2004-03-24       Impact factor: 9.776

  9 in total
  8 in total

Review 1.  Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer.

Authors:  Mostafa Akbarzadeh Khiavi; Azam Safary; Jaleh Barar; Amir Ajoolabady; Mohammad Hossein Somi; Yadollah Omidi
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

2.  Fabrication of triblock ABA type peptide dendrimer based on glutamic acid dimethyl ester and PEG as a potential nano drug delivery agent.

Authors:  Hassan Namazi; Yousef Toomari; Hassan Abbaspour
Journal:  Bioimpacts       Date:  2014-11-22

Review 3.  Perspective highlights on biodegradable polymeric nanosystems for targeted therapy of solid tumors.

Authors:  Marziyeh Fathi; Jaleh Barar
Journal:  Bioimpacts       Date:  2017-02-20

Review 4.  Stimuli-responsive chitosan-based nanocarriers for cancer therapy.

Authors:  Marziyeh Fathi; Parham Sahandi Zangabad; Sima Majidi; Jaleh Barar; Hamid Erfan-Niya; Yadollah Omidi
Journal:  Bioimpacts       Date:  2017-11-15

5.  A highly sensitive biosensor based on Au NPs/rGO-PAMAM-Fc nanomaterials for detection of cholesterol.

Authors:  Jianmeng Zhu; Zhilu Ye; Xiaoying Fan; Hongqin Wang; Zhen Wang; Bingyu Chen
Journal:  Int J Nanomedicine       Date:  2019-01-25

6.  Preparation, Physicochemical Assessment and the Antimicrobial Action of Hydroxyapatite-Gelatin/Curcumin Nanofibrous Composites as a Dental Biomaterial.

Authors:  Simin Sharifi; Asma Zaheri Khosroshahi; Solmaz Maleki Dizaj; Yashar Rezaei
Journal:  Biomimetics (Basel)       Date:  2021-12-27

7.  pH responsive cross-linked polymeric matrices based on natural polymers: effect of process variables on swelling characterization and drug delivery properties.

Authors:  Fahad Naeem; Samiullah Khan; Aamir Jalil; Nazar Muhammad Ranjha; Amina Riaz; Malik Salman Haider; Shoaib Sarwar; Fareha Saher; Samrin Afzal
Journal:  Bioimpacts       Date:  2017-08-16

Review 8.  Osteogenic Differentiation of Mesenchymal Stem Cells via Curcumin-Containing Nanoscaffolds.

Authors:  Khadijeh Khezri; Solmaz Maleki Dizaj; Yalda Rahbar Saadat; Simin Sharifi; Shahriar Shahi; Elham Ahmadian; Aziz Eftekhari; Elaheh Dalir Abdolahinia; Farzaneh Lotfipour
Journal:  Stem Cells Int       Date:  2021-07-17       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.